CXCR4 and neoplasm: The presence of CXCR4 has also been shown to correlate with metastatic disease in prostate cancer, where xenograft tumours that over expressed CXCR4 grafted into immunodeficient NOD/SCID mice exhibited increased growth, vessel density and metastasis [37].